The Oncology Nursing Society (ONS), the premier professional society for oncology nurses, turns 50 years old in 2025! During this year’s ONS annual meeting (the Congress) from April 9-13 in Denver, Colorado, this momentous anniversary will be celebrated with even more sessions and celebrations than the usual host of professional development, learning, and networking activities available at the Congress. ...
Advertisement
Latest News
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
A recent study offers perspectives from patients and healthcare professionals on telemedicine visits in RCC clinical trials.
Learn what oncology nurses should know about sarcopenia and why it's an increasingly recognized predictor of poor prognosis.
Proactive symptom management and patient education are essential, as treatment completion remains a challenge.
New research suggests that screening guidelines should be refined to account for asymptomatic brain metastases.
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
Martha Raymond, MA, of the GI Cancers Alliance, shares insights from a yearlong study that gathered patient perspectives.
Recent research highlights the need for proactive interventions by oncology nurses.
If patients who smoke understand the pathophysiology, they may be more open to difficult conversations about cessation.
The clinically focused intervention invovled a symptom assessment questionnaire followed by symptom support.
Study investigators say patients experienced improved functional capacity after surgery from the prehabilitation program.
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
Advertisement
Expert Interviews
Cancer Nursing Today delivers critical news and expert insights to support oncology nurses throughout their education and careers.
Sign up to receive Cancer Nursing Today eNewsletters:
Conference Highlights
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Martha Raymond, MA, of the GI Cancers Alliance, shares insights from a yearlong study that gathered patient perspectives.
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
A recent survey provides key insights into patient experiences with MIBC treatment and diagnosis over the past decade.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.